{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:06:04Z","timestamp":1790269564632,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bcmd.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T08:01:26Z","timestamp":1359187286000},"page":"281-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease"],"prefix":"10.1016","volume":"50","author":[{"given":"C\u00e9cile","family":"Braudeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Graveleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Rimbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"N\u00e9el","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Grosbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Besan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Giraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Terrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Josien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Masseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2013.01.001_bb0005","first-page":"309","article-title":"The enzymatic defect in Gaucher disease","volume":"95","author":"Brady","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0010","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10545-008-0868-z","article-title":"Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry","volume":"31","author":"Fairley","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0020","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1182\/blood.V86.12.4645.bloodjournal86124645","article-title":"Impaired microbicidal capacity of mononuclear phagocytes from patients with type I Gaucher disease: partial correction by enzyme replacement therapy","volume":"86","author":"Marodi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0025","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher Registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0030","first-page":"150450","article-title":"Gaucher disease and cancer: concept and controversy","author":"Choy","year":"2011","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/bcmd.1999.0237","article-title":"T cell numbers relate to bone involvement in Gaucher disease","volume":"25","author":"Lacerda","year":"1999","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0040","first-page":"149","article-title":"Abnormalities of cellular immunity and natural killer cells in Gaucher's disease","volume":"23","author":"Burstein","year":"1987","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0045","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/blood.V83.9.2646.2646","article-title":"Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation","volume":"83","author":"Liel","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0050","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1182\/blood.V84.7.2374.2374","article-title":"Significance of abnormal neutrophil chemotaxis in Gaucher's disease","volume":"84","author":"Zimran","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bcmd.2005.12.029","article-title":"Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal","volume":"36","author":"Micheva","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0060","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0070","doi-asserted-by":"crossref","first-page":"e18734","DOI":"10.1371\/journal.pone.0018734","article-title":"Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Rimbert","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0075","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/bmj.286.6381.1864","article-title":"Serum ferritin concentration in Gaucher's disease","volume":"286","author":"Morgan","year":"1983","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","article-title":"Hyperferritinemia and iron overload in type 1 Gaucher disease","volume":"85","author":"Stein","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcmd.2010.10.014","article-title":"Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease","volume":"46","author":"Stirnemann","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2012.04.002","article-title":"Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment","volume":"49","author":"Mekinian","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ymgme.2012.04.020","article-title":"Immunological cell type characterization and Th1\u2013Th17 cytokine production in a mouse model of Gaucher disease","volume":"106","author":"Pandey","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0105","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20060401","article-title":"Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation","volume":"203","author":"Guiducci","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0115","doi-asserted-by":"crossref","first-page":"26167","DOI":"10.1074\/jbc.M311591200","article-title":"Accumulation of glycosphingolipids in Niemann\u2013Pick C disease disrupts endosomal transport","volume":"279","author":"te Vruchte","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0120","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2","article-title":"Human peripheral blood contains two distinct lineages of dendritic cells","volume":"29","author":"Robinson","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.immuni.2008.09.002","article-title":"Antigen-presentation properties of plasmacytoid dendritic cells","volume":"29","author":"Villadangos","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.01.001_bb0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.0902-4441.2003.00193.x","article-title":"Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease","volume":"72","author":"Moller","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2013.01.001_bb0150","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","article-title":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease","volume":"35","author":"Deegan","year":"2005","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:17Z","timestamp":1761049757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979613000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1079979613000028"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.01.001","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}